• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

606-04-2 IC50

Background This is an updated version of the original Cochrane review

August 20, 2017 by Katherine Lewis Leave a Comment

Background This is an updated version of the original Cochrane review first published in Issue 4, 2009. 2011 and searched the MetaRegister for ongoing trials. Selection criteria Randomised controlled trials (RCTs) that compared adjuvant therapies (radiotherapy, chemotherapy followed by radiotherapy, or chemoradiation) with no radiotherapy or chemoradiation, in women with a confirmed histological diagnosis of … [Read more…]

Posted in: Blogging Tagged: 606-04-2 IC50, COG3

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by